HealthNotableConfirmedDeveloping
5.8
Polish regulators address illicit sale of Ozempic substitutes marketed as research peptides
RzeczpospolitaLO·PL·about 14 hours ago
Unregulated sellers are exploiting legal gaps to distribute counterfeit or unprescribed weight-loss medications via courier services. The Polish Pharmaceutical Inspection is currently pursuing regulatory amendments to curb these illicit shipments, though the efficacy of proposed enforcement remains uncertain.
Locations
Entities